Effect of mouth taping at night on asthma control
ISRCTN | ISRCTN74428617 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN74428617 |
Secondary identifying numbers | TC03/5 |
- Submission date
- 28/09/2005
- Registration date
- 15/11/2005
- Last edited
- 15/07/2010
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mrs Sue Cooper
Scientific
Scientific
Division Respiratory Medicine
Clinical Sciences Building
City Hospital
Nottingham
NG5 1PB
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Other |
Study type | Treatment |
Scientific title | |
Study objectives | Taping the mouth at night to ensure nose breathing will improve asthma control |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Asthma |
Intervention | Crossover design of taping mouth at night versus usual breathing |
Intervention type | Other |
Primary outcome measure | Morning peak expiratory flow and symptom scores |
Secondary outcome measures | 1. Evening peak flow 2. Diurnal variation in peak flow 3. FEV1 4. Beta-agonist use 5. Night time waking 6. Quality of life 7. Acceptability 8. Compliance with taping |
Overall study start date | 27/05/2004 |
Completion date | 31/05/2006 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 72 Years |
Sex | Both |
Target number of participants | 60 |
Key inclusion criteria | 1. Asthma 2. Age 18-72 3. Forced expiratory volume in one second (FEV1) over 50% predicted 4. Nocturnal or early morning symptoms 5. Pro re nata (prn) (as needed) beta-agonist use |
Key exclusion criteria | 1. Previous training in Buteyko technique 2. Inability to breathe through nose 3. Known sleep apnoea 4. Over 10 pack years smoking history 5. Other significant uncontrolled disease |
Date of first enrolment | 27/05/2004 |
Date of final enrolment | 31/05/2006 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Division Respiratory Medicine
Nottingham
NG5 1PB
United Kingdom
NG5 1PB
United Kingdom
Sponsor information
University of Nottingham (UK)
University/education
University/education
Research Innovation Services
University Park
Nottingham
NG7 2RD
England
United Kingdom
paul.cartledge@nottingham.ac.uk | |
https://ror.org/01ee9ar58 |
Funders
Funder type
Charity
British Lung Foundation (UK) - )ref: TC03/5)
Private sector organisation / Trusts, charities, foundations (both public and private)
Private sector organisation / Trusts, charities, foundations (both public and private)
- Alternative name(s)
- BLF
- Location
- United Kingdom
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/06/2009 | Yes | No |